Abstract
AbstractAtypical Antipsychotic Lurasidone Newly Approved for SchizophreniaMeta‐Analysis Finds Antipsychotics Superior to Mood Stabilizers in Acute ManiaAERS Detects Interaction between Paroxetine and PravastatinSwitching to an Antipsychotic with Lower Metabolic RiskRaloxifene Adjunctive to Antipsychotics in Postmenopausal SchizophreniaRisk of Psychotic Relapse with Haloperidol Discontinuation in AD PatientsVilazodone Long‐Term Safety and TolerabilitySertraline Response in Patients with and without DementiaImmediate‐Release Oxybutynin for Clozapine‐Induced SialorrheaMilnacipran Postmarketing Adverse EventsSafety Labeling Changes
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
